# Lansoprazole

NDC: 21130-046
Generic name: Lansoprazole
Labeler / Manufacturer: Albertsons Companies
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20220412

FDA application: ANDA202194

## Active ingredients

- LANSOPRAZOLE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"21130-046"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=21130-046
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96256d5f-f979-af82-6d92-e414d3e5240e